Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. scores highest on Nitro (65) and lowest on Price (3). Its PosiPenta is 39.77 out of 100, weaker than most similar companies.
On the Penta Grid this week, Madrigal Pharmaceuticals, Inc. is Grid #550 of 837 in the Healthcare sector in United States, and Grid #2,909 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. | 39.77 | 3 | 48 | 65 | 37 | 47 |
| Glaukos Corporation | 52.34 | 5 | 53 | 88 | 54 | 62 |
| The Ensign Group, Inc. | 62.30 | 38 | 69 | 76 | 54 | 75 |
| Oscar Health, Inc. | 65.04 | 41 | 76 | 93 | 68 | 48 |
| Insulet Corporation | 49.65 | 34 | 73 | 34 | 59 | 48 |
| BioMarin Pharmaceutical Inc. | 60.18 | 34 | 89 | 66 | 51 | 60 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -35.00 |
| P/B ratio | 19.84 |
EEarnings
| Trailing EPS | ₹-1217.09 |
| Forward EPS | ₹911.63 |
NNitro
| Price | 42597.10 |
| 52-week high | 58249.70 |
| 52-week low | 37280.75 |
| Fall from 52-week high | 26.9% |
TTorque
| Return on equity (ROE) | -53.31% |
| Debt-to-equity | 0.66 |
AAnchor
| Beta (price swings) | -1.05 |
| Market cap | ₹98,416 Cr |
| Insider holding | 5.83% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Madrigal Pharmaceuticals, Inc.'s PosiPenta score?
Madrigal Pharmaceuticals, Inc.'s PosiPenta is 39.77 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Madrigal Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, Madrigal Pharmaceuticals, Inc. is Grid #550 of 837 in the Healthcare sector in United States, and Grid #2,909 of 4,000 in United States.
Which PosiPenta pillar is strongest for Madrigal Pharmaceuticals, Inc.?
Nitro (momentum), with a score of 65 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Madrigal Pharmaceuticals, Inc.?
Price (valuation), with a score of 3 out of 100: much weaker than most similar companies.
Has Madrigal Pharmaceuticals, Inc.'s PosiPenta changed since last week?
Yes, it rose 11.43 points, from 28.34 to 39.77.
PositoAI is for research and education only and is not investment advice.